Novartis AG
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Last updated:
Abstract:
The present invention relates to therapeutic uses of compounds of formula (1) or a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
13 Nov 2018
Issue date:
5 Nov 2019